Introducing Dr. Alexandre Bétourné, RDCA-DAP Scientific Director C-Path is pleased to welcome Alexandre Bétourné, PhD, PharmD, as its new Scientific Director for the Rare Disease Cures Accelera
Welcome Dr. Martijn Muller as CPP Senior Scientific Director C-Path is pleased to welcome Martijn Muller, PhD, as Senior Scientific Director for the Critical Path for Parkinson Consortium. Pr
C-Path’s Data Collaboration Center Seeks Proposals The Critical Path Institute Data Collaboration Center is seeking proposals for the creation of non-identifiable, synthetic patient
C-Path and EATRIS To Collaborate on RDCA-DAP C-Path has signed a Memorandum of Understanding with EATRIS, the European infrastructure for translational medicine, to accelerate
C-Path Awarded FDA Drug Development Tool Research Grant to Develop a Qualification Plan for the Symptoms of Major Depressive Disorder Momentary Assessment (SMDDMA) C-Path’s Patient-Reported Outcome (PRO) Consortium announced that it has been awarded a U.S. Food and Drug Administration (FDA)
C-Path Awarded FDA Drug Development Tool Research Grant to Develop a Qualification Plan for the PROMIS® Short Form v2.1—Physical Function-Multiple Sclerosis 15a (PROMIS PFMS—15a) C-Path’s Patient-Reported Outcome (PRO) Consortium announced today it has been awarded a U.S. Food and Drug Administratio
August 25, 2020 Biomarkers of Crohn’s Disease to Support the Development of New Therapeutic Interventions C-Path’s Crohn's Disease Biomarkers Pre-Consortium funded by The Helmsley Charitable Trust is proud to announce its...
C-Path’s PKDOC and The PKD Foundation Set to Collaborate Once Again Polycystic Kidney Disease (PKD) is an inherited disorder in which clusters of cysts develop in the kidneys. There are more than 20
ePRO Consortium Announces Publication of Open Access Article C-Path’s ePRO Consortium is pleased to announce that “Demystifying Submissions of eCOA Documentation for Ethics
C-Path Partners with CHDR to Expand Global Collaborations The Critical Path Institute and the Centre for Human Drug Research (CHDR) have joined forces to expand global collaborations for b